Personalized Medicine Series: What You Need to Know about Stem Cell Tourism

What You Need to Know about Stem Cell Tourism
in partnership with the Johns Hopkins Berman Institute of Bioethics

In this panel discussion held at NYSCF headquarters, members of the John Hopkins Berman Institute of Bioethics, patient advocates, and scientists engaged in a discussion exploring the ethics and decision-making of stem cell treatments around the world. What rights should terminally ill and desperate patients have to try experimental treatments? Who gets to decide and what is the path forward? This conversation was part of NYSCF’s Science & Society series. Support for the event was provided by the Stavros Niarchos Foundation.

Read a summary of the event here.

Speakers (L-R):

David Carmel, MBA
Head of Immunotherapy, Atara Biotherapeutics

Francesco Clark
SVP, Glansaol; President & CEO, Clark’s Botanicals

Jeffrey Kahn, PhD, MPH
Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics

Susan L. Solomon, JD
CEO & Co-Founder, NYSCF